Diagnostic value of serum peptidome analyses for protease activated pathological conditions beyond cancer diagnosis

Medical Hypotheses

Volumn 73, Issue 5, 2009, Pages 760-763

  Hashiguchi, Teruto ^a   Tanaka, Kenji ^b   Lee, Lyang Ja ^b   Sasaki, Ken ^a   Natsugoe, Shoji ^a   Kawahara, Ko ichi ^a   Arimura, Kimiyoshi ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Protosera Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; PEPTIDE DERIVATIVE; PREALBUMIN; PROTEINASE;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME ACTIVATION; ENZYME ACTIVITY; GEL ELECTROPHORESIS; HUMAN; MASS SPECTROMETRY; MULTIPLE ORGAN FAILURE; NUTRITIONAL SUPPORT; POEMS SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE DIAGNOSIS;

AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDE HYDROLASES; PEPTIDES; PREALBUMIN; PROTEOME;

EID: 70349728455     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.04.026     Document Type: Article

References (17)

1. Richter R., Schulz-Knappe P., Schrader M., Standker L., Jurgens M., Tammen H., et al. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatogr 726 (1999) 25-35
2. Tirumalai R.S., Chan K.C., Prieto D.A., Issaq H.J., Conrads T.P., and Veenstra T.D. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2 (2003) 1096-1103
3. Koomen J.M., Li D., Xiao L.C., Liu T.C., Coombes K.R., Abbruzzese J., et al. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res 4 (2005) 972-981
4. Villanueva J., Shaffer D.R., Philip J., Chaparro C.A., Erdjument-Bromage H., Olshen A.B., et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116 (2006) 271-284
5. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
6. Tanaka K., Tsugawa N., Kim Y.O., Sanuki N., Takeda U., and Lee L.J. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry. Biochem Biophys Res Commun 379 (2009) 110-114
7. Nakanishi T., Sobue I., Toyokura Y., Nishitani H., Kuroiwa Y., Satoyoshi E., et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 34 (1984) 712-720
8. Dispenzieri A., Kyle R.A., Lacy M.Q., Rajkumar S.V., Therneau T.M., Larson D.R., et al. POEMS syndrome: definitions and long-term outcome. Blood 101 (2003) 2496-2506
9. Dispenzieri A. POEMS syndrome. Blood Rev 21 (2007) 285-299
10. Watanabe O., Arimura K., Kitajima I., Osame M., and Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347 (1996) 702
11. Niimi H., Arimura K., Jonosono M., Hashiguchi T., Kawabata M., Osame M., et al. VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome. Intern Med (Tokyo, Japan) 39 (2000) 1101-1104
12. Hashiguchi T., Arimura K., Matsumuro K., Otsuka R., Watanabe O., Jonosono M., et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 23 (2000) 1051-1056
13. Tokashiki T., Hashiguchi T., Arimura K., Eiraku N., Maruyama I., and Osame M. Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome. Intern Med (Tokyo, Japan) 42 (2003) 1240-1243
14. Lowenthal M.S., Mehta A.I., Frogale K., Bandle R.W., Araujo R.P., Hood B.L., et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 51 (2005) 1933-1945
15. Liotta L.A., and Petricoin E.F. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest 116 (2006) 26-30
16. Petricoin E.F., Belluco C., Araujo R.P., and Liotta L.A. The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev 6 (2006) 961-967
17. Joyce J.A. Therapeutic targeting of the tumor microenvironment. Cancer Cell 7 (2005) 513-520